ClinicalTrials.gg
CompletedNCT07824427Updated Oct 9, 2026

AI-Generated Video Distraction Via Virtual Reality for Fear and Pain During Pediatric Circumcision

An interventional study of AI-Generated Video Distraction via Virtual Reality in Procedural Pain Relief, Virtual Reality and Fear, sponsored by Yuzuncu Yil University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 4 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2026, registered Sep 2026).
Updated Oct 9, 2026Start date movedPrimary completion moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 78 studies in Pain, Procedural with a site in Turkey — 13 open to participants now, 13 under way, none of them phase 3. Pain, Procedural · Turkey.

Enrollment
53rd of 76
80 · median 100
Started
2026
with 17 others
No phase
74 of 78
12 open now
Registered
69th of 78
by date

Among the 78 studies in Pain, Procedural with a site in Turkey, this one is the 53rd largest by enrollment of the 76 interventional ones that give a count, is one of 18 that started in 2026, is one of 74 with no phase, and was the 69th registered.

Pain, Procedural

241 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

Browse Pain, Procedural studies →

Open to participants now

13 of the 78 studies in Pain, Procedural with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 29 Pain, Procedural studies recruiting now, 13 (45%) set no upper age limit and 14 (48%) stop at 75 or younger; 14 take children under 18; 5 take healthy volunteers.

This study: 4 Years to 12 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Pain, Procedural with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial evaluated the effect of artificial intelligence-generated video distraction delivered via virtual reality on procedural fear and pain in children undergoing circumcision. A total of 80 children aged 4-12 years were assigned to an intervention group (n=40) or a control group (n=40). Children in the intervention group received AI-generated video distraction via virtual reality, whereas children in the control group received routine care. Pain and emotional responses were assessed from the perspectives of the child, parent, and nurse. Physiological parameters were also measured before and after the procedure. The study aimed to determine whether AI-generated video distraction delivered via virtual reality reduces procedural fear and pain during pediatric circumcision.

03

Conditions studied

  • Procedural Pain Relief
  • Virtual Reality
  • Fear
  • Child
  • Digital Health
  • Generative Artificial Intelligence
  • Artificial Intelligence (AI)
  • Circumcision, Male

Browse trials for

Keywords

  • Circumcision, Male
  • Virtual Reality
  • Generative Artificial Intelligence
  • Child
04

Who can participate

The criteria were revised on the registry on Oct 9, 2026. See what changed

Ages eligible
4 Years to 12 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male children aged 4 to 12 years.
  • Children scheduled to undergo circumcision.
  • Participation in the study with parental consent.

Exclusion criteria

Exclusion Criteria:

  • Presence of a neurodevelopmental disorder.
  • Visual or hearing impairment that prevents viewing the video or completing the scales.
  • History of epilepsy.
  • History of motion sickness.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    AI-Generated Video Distraction via Virtual Reality

    Children in the intervention group watched a 3-minute artificial intelligence-generated video through a virtual reality headset before circumcision, in addition to routine care.

    Behavioral: AI-Generated Video Distraction via Virtual Reality

  • No intervention
    Control Group

    Children in the control group received routine care without the virtual reality video intervention.

Interventions

  • BehavioralAI-Generated Video Distraction via Virtual Reality

    Artificial intelligence-generated video content is presented through a virtual reality headset as a distraction intervention for children undergoing circumcision. The intervention is intended to reduce procedural fear and pain.

06

What researchers measure

Primary outcomes

  1. Pain Scores at the Post-Test Assessment

    Pain intensity was assessed using the Wong-Baker FACES Pain Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate greater pain intensity. The child, parent, and nurse independently rated the child's pain. Baseline pain was also assessed 30 minutes before circumcision in both groups.

    Time frame: 1 hour after circumcision.

Secondary outcomes

  1. Preoperative Fear Scores

    Child-reported fear was assessed using the six-face Scary Scale, with scores ranging from 0 to 10. Higher scores indicate greater fear. Separate parent and nurse ratings of the child's fear were also recorded.

    Time frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.

  2. Preoperative State Anxiety Scores

    Child-reported state anxiety was assessed using the Children's Anxiety Meter-State, a thermometer-like scale ranging from 0 to 10. Higher scores indicate greater anxiety. Separate parent and nurse ratings of the child's anxiety were also recorded.

    Time frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.

  3. Heart Rate

    Heart rate was measured in beats per minute in both groups.

    Time frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.

  4. Body Temperature

    Body temperature was measured in degrees Celsius in both groups.

    Time frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.

  5. Peripheral Oxygen Saturation

    Peripheral oxygen saturation (SpO2) was measured as a percentage in both groups.

    Time frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.

  6. Respiratory Rate

    Respiratory rate was measured in breaths per minute in both groups.

    Time frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.

07

Study locations

1 site
  • Van Yüzüncü Yıl University Dursun Odabaş Medical Center
    Van, Van 65080, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to participant privacy and confidentiality considerations.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Sep 2026, 3 months.

Of 141 non-industry interventional studies with no phase under Pain, Procedural, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 3 months is below that.

Counting every sponsor, half of 141 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: start Oct 2025 → Jun 2026, primary completion May 2026 → Sep 2026 and completion Aug 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2026
First posted
Sep 17, 2026
StartActual
Jun 1, 2026was Oct 2025
Primary completionActual
Sep 23, 2026was May 2026
CompletionActual
Sep 23, 2026was Aug 2026
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 17, 2025→Jun 1, 2026
Oct 9, 2026
Primary completion
May 5, 2026→Sep 23, 2026
Oct 9, 2026
Study completion
Aug 11, 2026→Sep 23, 2026
Oct 9, 2026
Eligibility
4 exclusion criteria added, 1 removed
What changed in the criteria
Exclusion criteria
  • Removed- Children who did not meet the study inclusion criteria.
  • AddedPresence of a neurodevelopmental disorder.
  • AddedVisual or hearing impairment that prevents viewing the video or completing the scales.
  • AddedHistory of epilepsy.
  • AddedHistory of motion sickness.
Oct 9, 2026
Primary outcomes
1 time frame changed, 1 description edited
What changed in the outcomes
  • Time framePain Scores at the Post-Test AssessmentImmediately after the circumcision procedure → 1 hour after circumcision.
  • DescriptionPain Scores at the Post-Test Assessment: how it is measured was reworded
Oct 8, 2026
Secondary outcomes
6 added
What changed in the outcomes
  • AddedPreoperative Fear ScoresTime frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.
  • AddedPreoperative State Anxiety ScoresTime frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.
  • AddedHeart RateTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
  • AddedBody TemperatureTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
  • AddedPeripheral Oxygen SaturationTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
  • AddedRespiratory RateTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
Oct 8, 2026
Show all 2 updates
  1. Oct 9, 2026
    Start date Oct 17, 2025→Jun 1, 2026
    Primary completion May 5, 2026→Sep 23, 2026
    Study completion Aug 11, 2026→Sep 23, 2026
    Eligibility 4 exclusion criteria added, 1 removed
    What changed in the criteria
    Exclusion criteria
    • Removed- Children who did not meet the study inclusion criteria.
    • AddedPresence of a neurodevelopmental disorder.
    • AddedVisual or hearing impairment that prevents viewing the video or completing the scales.
    • AddedHistory of epilepsy.
    • AddedHistory of motion sickness.
    + 1 other change: verification date
  2. Oct 8, 2026
    Primary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time framePain Scores at the Post-Test AssessmentImmediately after the circumcision procedure → 1 hour after circumcision.
    • DescriptionPain Scores at the Post-Test Assessment: how it is measured was reworded
    Secondary outcomes 6 added
    What changed in the outcomes
    • AddedPreoperative Fear ScoresTime frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.
    • AddedPreoperative State Anxiety ScoresTime frame: Immediately before and immediately after the 3-minute preoperative video in the intervention group. Once at the corresponding baseline time point in the control group.
    • AddedHeart RateTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
    • AddedBody TemperatureTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
    • AddedPeripheral Oxygen SaturationTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
    • AddedRespiratory RateTime frame: 30 minutes before circumcision and 1 hour after circumcision in both groups.
    + 1 other change: arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07824427
Lead sponsor
Yuzuncu Yil University
Responsible party
mehmet bulduk (Principal Investigator, Yuzuncu Yil University) — Principal investigator
First posted
Sep 17, 2026
Start date
Jun 1, 2026
Primary completion
Sep 23, 2026
Completion
Sep 23, 2026
Last update
Oct 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion